These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23299493)

  • 1. Fucoxanthin enhances cisplatin-induced cytotoxicity via NFκB-mediated pathway and downregulates DNA repair gene expression in human hepatoma HepG2 cells.
    Liu CL; Lim YP; Hu ML
    Mar Drugs; 2013 Jan; 11(1):50-66. PubMed ID: 23299493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of curcumin and cisplatin via down-regulation of thymidine phosphorylase and excision repair cross-complementary 1 (ERCC1).
    Tsai MS; Weng SH; Kuo YH; Chiu YF; Lin YW
    Mol Pharmacol; 2011 Jul; 80(1):136-46. PubMed ID: 21493726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demethoxycurcumin sensitizes the response of non-small cell lung cancer to cisplatin through downregulation of TP and ERCC1-related pathways.
    Lin CY; Hung CC; Wang CCN; Lin HY; Huang SH; Sheu MJ
    Phytomedicine; 2019 Feb; 53():28-36. PubMed ID: 30668408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
    Xia A; Li H; Li R; Lu L; Wu X
    Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
    Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Apoptosis in Human Glioma Cells by Fucoxanthin via Triggering of ROS-Mediated Oxidative Damage and Regulation of MAPKs and PI3K-AKT Pathways.
    Wu HL; Fu XY; Cao WQ; Xiang WZ; Hou YJ; Ma JK; Wang Y; Fan CD
    J Agric Food Chem; 2019 Feb; 67(8):2212-2219. PubMed ID: 30688446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role and mechanisms of microRNA‑503 in drug resistance reversal in HepG2/ADM human hepatocellular carcinoma cells.
    Wang D; Zhang N; Ye Y; Qian J; Zhu Y; Wang C
    Mol Med Rep; 2014 Dec; 10(6):3268-74. PubMed ID: 25269574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of proliferation of a hepatoma cell line by fucoxanthin in relation to cell cycle arrest and enhanced gap junctional intercellular communication.
    Liu CL; Huang YS; Hosokawa M; Miyashita K; Hu ML
    Chem Biol Interact; 2009 Dec; 182(2-3):165-72. PubMed ID: 19737546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D.
    Das SK; Hashimoto T; Kanazawa K
    Biochim Biophys Acta; 2008 Apr; 1780(4):743-9. PubMed ID: 18230364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73.
    Wong SW; Tiong KH; Kong WY; Yue YC; Chua CH; Lim JY; Lee CY; Quah SI; Fow C; Chung C; So I; Tan BS; Choo HL; Rosli R; Cheong SK; Leong CO
    Breast Cancer Res Treat; 2011 Jul; 128(2):301-13. PubMed ID: 20686837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfasalazine synergistically enhances the inhibitory effects of imatinib against hepatocellular carcinoma (HCC) cells by targeting NFκB, BCR/ABL, and PI3K/AKT signaling pathway-related proteins.
    Shamaa MM
    FEBS Open Bio; 2021 Mar; 11(3):588-597. PubMed ID: 33289342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways.
    Yang L; Hu Y; Zhou G; Chen Q; Song Z
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-PKcs deficiency sensitizes the human hepatoma HepG2 cells to cisplatin and 5-fluorouracil through suppression of the PI3K/Akt/NF-κB pathway.
    Fang Y; Chai Z; Wang D; Kuang T; Wu W; Lou W
    Mol Cell Biochem; 2015 Jan; 399(1-2):269-78. PubMed ID: 25348361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of anti-hepatoma agents from 1,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine by inhibiting PI3K/AKT/NF-κB pathway activation.
    Zhou YQ; Sun Y; Luo HL; Gao ZF; Zhang HQ; Meng QG; Bai XY; Hou GG; Hou Y
    Eur J Med Chem; 2021 Dec; 225():113796. PubMed ID: 34450496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct repair.
    Kudo K; Gavin E; Das S; Amable L; Shevde LA; Reed E
    Oncogene; 2012 Nov; 31(44):4718-24. PubMed ID: 22266871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells.
    Liu Y; Zheng J; Zhang Y; Wang Z; Yang Y; Bai M; Dai Y
    Neurochem Res; 2016 Oct; 41(10):2728-2751. PubMed ID: 27394418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells.
    Grabinski N; Ewald F; Hofmann BT; Staufer K; Schumacher U; Nashan B; Jücker M
    Mol Cancer; 2012 Nov; 11():85. PubMed ID: 23167739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway.
    Zhou Y; Zhang M; Zhang Z; Jia Y; Zhang C; Peng L
    Biomed Pharmacother; 2020 Sep; 129():109851. PubMed ID: 32559627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fucoxanthin prevents cell growth and induces apoptosis in endometrial cancer HEC-1A cells by the inhibition of the PI3K/Akt/mTOR pathway.
    Qu J; Sun Y; Yang L; Niu X; Li L
    J Biochem Mol Toxicol; 2022 Jun; 36(6):e23027. PubMed ID: 35266250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma.
    Ha SE; Kim SM; Vetrivel P; Kim HH; Bhosale PB; Heo JD; Lee HJ; Kim GS
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.